ASCENDIS HEALTH LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.78 ZAR | 0.00% |
|
-3.70% | 0.00% |
| Mar. 29 | Ascendis Health Seeks Acquisitions | CI |
| Mar. 28 | Ascendis Health Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Presenter SpeechJohn Bester (Executives)In terms of article 20.5.1, the company's memorandum o...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Ascendis Health Limited specializes in developing, manufacturing and marketing care and health products. Net sales break down by family of products as follows:
- pharmaceutical products (61.3%): primarily prescription drugs. The group also provides medical devices used in the radiology and surgery fields;
- consumer products (31%): OTC medicines, vitamins and minerals, homeopathic products, ayurvedic products, sports nutrition products, functional foods, etc.;
- care products for plants and animals (7.7%).
Net sales are distributed geographically as follows: South Africa (71.3%), Cyprus (16%) and Romania (12.7%).
Sector
Pharmaceuticals
Calendar
2024-09-25
- Q4 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 26.87M | |
| +32.09% | 693B | |
| +29.39% | 584B | |
| -1.34% | 372B | |
| +20.34% | 332B | |
| +7.39% | 294B | |
| +14.25% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +8.49% | 168B |
- Stock Market
- Equities
- ASC Stock
- News Ascendis Health Limited
- Transcript : Ascendis Health Limited - Shareholder/Analyst Call